Cancer Treatment Centers of America

We're available 24/7
(800) 615-3055

Chat online with us

Chat now

Other ways to contact us

Video
chat
(800) 615-3055

Have questions? Call (800) 615-3055 to speak to a cancer information specialist.
Or we can call you.

Press Releases from CTCA

Ovarian Cancer Vaccine Clinical Trial Extended to Two Additional Cancer Treatment Centers of America Hospitals

Ovarian Cancer Vaccine Clinical Trial Extended to Two Additional Cancer Treatment Centers of America Hospitals

Cancer Treatment Centers of America® (CTCA) is now enrolling patients in an ovarian cancer vaccine clinical trial at all five of its hospitals. CTCA at Western Regional Medical Center in suburban Phoenix and CTCA at Southeastern Regional Medical Center in suburban Atlanta are the newest sites to participate in the Phase I/II study. The study evaluates the safety and immune stimulating activity of a unique ovarian cancer vaccine therapy in patients with recurrent ovarian cancer.

Your browser (Internet Explorer 7) is out of date. Learn how to update your browser.